The Centers for Disease Control and Prevention (CDC) says {that a} preliminary COVID-19 vaccine “security sign” has been recognized and is investigating whether or not the Bivalent Pfizer-BioNTech vaccine creates an elevated danger of ischemic stroke in individuals 65 and older.
In the Friday assertion, the CDC mentioned that the preliminary sign hasn’t been recognized with the Bivalent Moderna COVID-19 vaccine.
“Following the supply and use of the up to date (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a close to real-time surveillance system, met the statistical standards to immediate further investigation into whether or not there was a security concern for ischemic stroke in individuals ages 65 and older who acquired the Pfizer-BioNTech COVID-19 Vaccine, Bivalent,” the CDC mentioned.
“Rapid-response investigation of the sign within the VSD raised a query of whether or not individuals 65 and older who’ve acquired the Pfizer-BioNTech COVID-19 Vaccine, Bivalent had been extra more likely to have an ischemic stroke within the 21 days following vaccination in contrast with days 22-44 following vaccination.”
According to the CDC, an ischemic stroke “happens when blood clots or different particles block the blood vessels to the mind.”
COVID XBB.1.5 VARIANT NOW ACCOUNTS FOR 43% OF ALL US CASES, CDC SAYS
A syringe is ready with the Pfizer COVID-19 vaccine at a vaccination clinic on the Keystone First Wellness Center in Chester, Pennsylvania, on Dec. 15, 2021.
(AP Photo/Matt Rourke, File )
In the assertion, the CDC identified that a big examine of up to date bivalent vaccines from Pfizer-BioNTech “utilizing the Centers for Medicare and Medicaid Services database revealed no elevated danger of ischemic stroke.”
The company additionally mentioned that the Vaccine Adverse Event Reporting System (VAERS) managed by CDC and FDA has not seen a rise in reporting of ischemic strokes following the up to date (bivalent) vaccine.
In a press release to PeyNews Digital, a spokesperson for Pfizer mentioned, “Pfizer and BioNTech have been made conscious of restricted reviews of ischemic stroke which were noticed within the CDC Vaccine Safety DataLink (VSD) database in individuals 65 and older following vaccination with the Omicron BA.4/BA.5-adapted bivalent COVID-19 Vaccine by Pfizer and BioNTech.”
COVID OMICRON SUBVARIANT XBB: WHY THE NUMBER OF CASES IS LIKELY FAR GREATER THAN REPORTED
Liesl Eibschutz, a medical pupil from Dartmouth University, hundreds a syringe with Pfizer COVID-19 vaccine earlier than giving it to individuals on the primary day that individuals ages 16 and up can obtain the vaccine at Kedren Health in Los Angeles on April 15, 2021.
( Allen J. Schaben / Los Angeles Times through Getty Images)
“Neither Pfizer and BioNTech nor the CDC or the U.S. Food and Drug Administration (FDA) have noticed related findings throughout quite a few different monitoring techniques within the U.S. and globally and there’s no proof to conclude that ischemic stroke is related to using the businesses’ COVID-19 vaccines,” the spokesperson continued.
“Compared to printed incidence charges of ischemic stroke on this older inhabitants, the businesses so far have noticed a decrease variety of reported ischemic strokes following the vaccination with the Omicron BA.4/BA.5-adapted bivalent vaccine. The CDC continues to advocate vaccination with the Pfizer-BioNTech Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for all licensed ages and indications.”
CLICK HERE TO GET THE PeyNews APP
This August 2022 photograph reveals vials of Pfizer’s up to date COVID-19 vaccine throughout manufacturing in Kalamazoo, Michigan.
(Pfizer through AP)
The CDC is not recommending a change in vaccine observe.
PeyNews medical contributor Dr. Marc Siegel mentioned that this is not “proof” of a hyperlink between the vaccine and strokes.
“This is just not proof. This is that they see there could also be a hyperlink right here, and so they wish to examine it, and so they’re attempting to be clear,” he mentioned.